---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-100971"
form_type: "8-K"
ticker: "NEUP"
cik: "0001191070"
company_name: "Neuphoria Therapeutics Inc."
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T20:25:03.475597+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Bionomics enters $2M ATM offering with H.C. Wainwright, replaces prior $11.5M program

## Summary
- Signed ATM agreement with H.C. Wainwright for up to $2 million in ADSs; 3.0% sales commission.
- Prior $11.5M ATM program with Cantor Fitzgerald terminated before signing new agreement.
- Shelf registration on Form S-3 filed Nov 18, 2024 (File No. 333-283306) for the offering.
- Sales agent may sell ADSs on Nasdaq at market prices; no minimum required sales.

## SEC filing metadata
- accession: 0001213900-24-100971
- form_type: 8-K
- ticker: NEUP
- cik: 0001191070
- company_name: Neuphoria Therapeutics Inc.
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1191070/000121390024100971/0001213900-24-100971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1191070/000121390024100971/ea0221911-8k_bionom.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-100971
- JSON: https://secwatch.observer/filing/0001213900-24-100971.json
- Plain text: https://secwatch.observer/filing/0001213900-24-100971.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.